Literature DB >> 25139884

Increased serum calcium levels and risk of type 2 diabetes in individuals at high cardiovascular risk.

Nerea Becerra-Tomás1, Ramón Estruch2, Mònica Bulló1, Rosa Casas2, Andrés Díaz-López1, Josep Basora1, Montserrat Fitó3, Lluis Serra-Majem4, Jordi Salas-Salvadó5.   

Abstract

OBJECTIVE: Insulin resistance and secretion depend on calcium homeostasis. Cross-sectional studies have associated elevated serum calcium levels with markers of impaired glucose metabolism. However, only one prospective cohort study has demonstrated an increased risk of diabetes in individuals with increased serum calcium concentrations. The aim of the current study was to prospectively investigate the association between albumin-adjusted serum calcium concentrations and type 2 diabetes in subjects at high cardiovascular risk. RESEARCH DESIGN AND METHODS: Prospective assessment of participants from two Spanish PREDIMED study centers where serum calcium levels were measured at baseline and yearly during follow-up. Multivariate-adjusted Cox regression models were fitted to assess associations between baseline and changes during follow-up in serum calcium levels and relative risk of diabetes incidence.
RESULTS: After a median follow-up of 4.78 years, 77 new cases of type 2 diabetes occurred. An increase in serum calcium levels during follow-up was related to an increased risk of diabetes. In comparison with individuals in the lowest tertile (-0.78 ± 0.29 mg/dL), the hazard ratio (HR) and 95% CI for diabetes incidence in individuals in the higher tertile of change (0.52 ± 0.13 mg/dL) during follow-up was 3.48 (95% CI 1.48-8.17; P for trend = 0.01). When albumin-adjusted serum calcium was analyzed as a continuous variable, per 1 mg/dL increase, the HR of diabetes incidence was 2.87 (95% CI 1.18-6.96; P value = 0.02). These associations remained significant after individuals taking calcium supplements or having calcium levels out of normal range had been excluded.
CONCLUSIONS: An increase in serum calcium concentrations is associated with an increased risk of type 2 diabetes in individuals at high cardiovascular risk.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25139884     DOI: 10.2337/dc14-0898

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  27 in total

1.  Circulating calcium levels and the risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  J Zhu; P Xun; J C Bae; J H Kim; D J Kim; K Yang; K He
Journal:  Br J Nutr       Date:  2019-08-28       Impact factor: 3.718

2.  Serum calcium and incident diabetes: an observational study and meta-analysis.

Authors:  C W Sing; V K F Cheng; D K C Ho; A W C Kung; B M Y Cheung; I C K Wong; K C B Tan; J Salas-Salvadó; N Becerra-Tomas; C L Cheung
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

3.  Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Mary R Rooney; James S Pankow; Shalamar D Sibley; Elizabeth Selvin; Jared P Reis; Erin D Michos; Pamela L Lutsey
Journal:  Am J Clin Nutr       Date:  2016-08-10       Impact factor: 7.045

4.  The Predictive Value of Serum Calcium on Heart Rate Variability and Cardiac Function in Type 2 Diabetes Patients.

Authors:  Junyi Wang; Zihui Xu; Kang Lv; Yingchun Ye; Deng Luo; Li Wan; Fen Zhou; Ailin Yu; Shuo Wang; Jingcheng Liu; Ling Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

5.  Cross-sectional analysis of serum calcium levels for associations with left ventricular hypertrophy in normocalcemia individuals with type 2 diabetes.

Authors:  Junfeng Li; Nan Wu; Yintao Li; Kuanping Ye; Min He; Renming Hu
Journal:  Cardiovasc Diabetol       Date:  2015-04-29       Impact factor: 9.951

6.  Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes.

Authors:  Junfeng Li; Nan Wu; Wenling Dai; Liu Jiang; Yintao Li; Shibao Li; Zhongyuan Wen
Journal:  Cardiovasc Diabetol       Date:  2016-10-03       Impact factor: 9.951

7.  The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years.

Authors:  Ting-Ting Liu; Dong-Mei Liu; Yan Xuan; Lin Zhao; Li-Hao Sun; Dian-Dian Zhao; Xiao-Feng Wang; Yang He; Xing-Zhi Guo; Rui Du; Ji-Qiu Wang; Jian-Min Liu; Hong-Yan Zhao; Bei Tao
Journal:  Bone Res       Date:  2017-07-04       Impact factor: 13.567

8.  Serum Calcium Concentration Is Inversely Associated With Radiographic Knee Osteoarthritis: A Cross-Sectional Study.

Authors:  Hui Li; Chao Zeng; Jie Wei; Tuo Yang; Shu-Guang Gao; Yu-Sheng Li; Wei Luo; Wen-Feng Xiao; Yi-Lin Xiong; Guang-Hua Lei
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

9.  Association of serum calcium concentrations with fibrinogen and homocysteine in nondiabetic Korean subjects.

Authors:  Hyun Sun Cho; Sung Won Lee; Juyoung Shin; Sung Dae Moon; Je Ho Han; Bong Yun Cha; Eun Sook Kim
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial.

Authors:  Osama Sawalmeh; Shaheed Moala; Zakaria Hamdan; Huda Masri; Khubaib Ayoub; Emad Khazneh; Mujahed Shraim
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.